Ratan Tata to lay foundations for a 300 bed cancer hospital in Ranchi

Ratan Tata, the chairman emeritus of Tata Sons and the chairman of Tata Trusts, will lay the foundations for a the hospital cum research center on Saturday.

The hospital will come up on 23 acres of land donated by the state department of health, medical education and family welfare department to the Tata Trusts in Kanke on the outskirts of the state capital earlier this year.

Jharkhand health secretary Nitin Madan Kulkarni said the first phase of the hospital is expected to become operational with 150 beds by 2022. “Once operational, it will cater to thousands of cancer patients of Jharkhand who visit different states for treatment every year,” Kulkarni added.

The groundbreaking comes less than a week before Jharkhand is due to observe the 18th statehood day.

State government had said seeds of the hospital were sown during the inaugural session of the Momentum Jharkhand Global Investment Summit held in February 2017 when Jharkhand chief minister Raghubar Das approached Tata and floated the idea of building a cancer care center, which the latter agreed to.

With Jharkhand lacking a robust cancer treatment infrastructure in its state run tertiary and secondary healthcare centers, the health department has approached the Tata Trusts to handhold in setting up screening facilities in government healthcare centers.

  • Related Posts

    Medicines that cure Us are making Our Environment Sick

    Antimicrobial Resistance Campaigner makes a Fervent Appeal for Safe Disposal of Leftover Medicines New Delhi: We invariably worry about what might be the side effects of medicines on our body…

    ZEN- G packs a punch in Organ Donation as Over 500 Students pledge Organs

    National Organ Transplant Games2026 set World Record in Talkatora Indoor Stadium New Delhi: The National Organ Transplant Games began on a high note in Talkatora Indoor Stadium on November 1,…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

    PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

    Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

    Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

    From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels

    From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels

    UP expands food, drug testing capacity across all 18 divisions

    UP expands food, drug testing capacity across all 18 divisions

    Abbott receives US FDA approval and CE Mark for the UltiSynq defibrillation lead

    Abbott receives US FDA approval and CE Mark for the UltiSynq defibrillation lead

    Medicines worth ₹14 lakh seized from unlicensed residential premises in Delhi

    Medicines worth ₹14 lakh seized from unlicensed residential premises in Delhi